Voloridge Investment Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-87,981
Closed -$478K 1346
2024
Q4
$478K Sell
87,981
-234,954
-73% -$1.28M ﹤0.01% 1103
2024
Q3
$2.33M Sell
322,935
-106,902
-25% -$772K 0.01% 921
2024
Q2
$4.67M Sell
429,837
-122,804
-22% -$1.33M 0.02% 764
2024
Q1
$10.4M Buy
552,641
+159,942
+41% +$3M 0.04% 483
2023
Q4
$8.51M Buy
392,699
+321,731
+453% +$6.97M 0.03% 507
2023
Q3
$1.46M Buy
+70,968
New +$1.46M 0.01% 1015
2022
Q3
Sell
-132,101
Closed -$4.27M 1596
2022
Q2
$4.27M Buy
132,101
+87,661
+197% +$2.83M 0.02% 735
2022
Q1
$1.47M Sell
44,440
-89,805
-67% -$2.97M 0.01% 1041
2021
Q4
$5.71M Sell
134,245
-105,962
-44% -$4.51M 0.03% 674
2021
Q3
$10.6M Buy
240,207
+93,661
+64% +$4.15M 0.07% 408
2021
Q2
$8.33M Sell
146,546
-20,513
-12% -$1.17M 0.06% 468
2021
Q1
$12.5M Sell
167,059
-7,640
-4% -$572K 0.09% 291
2020
Q4
$15.1M Buy
174,699
+9,452
+6% +$818K 0.13% 197
2020
Q3
$10.1M Sell
165,247
-182,106
-52% -$11.1M 0.08% 261
2020
Q2
$14.4M Buy
347,353
+143,641
+71% +$5.97M 0.17% 129
2020
Q1
$5.85M Buy
203,712
+187,161
+1,131% +$5.38M 0.17% 134
2019
Q4
$1.2M Sell
16,551
-973
-6% -$70.3K 0.02% 600
2019
Q3
$2.46M Buy
+17,524
New +$2.46M 0.04% 399
2018
Q1
Sell
-53,908
Closed -$8.88M 633
2017
Q4
$8.88M Buy
+53,908
New +$8.88M 0.19% 129
2017
Q3
Sell
-73,953
Closed -$5.89M 516
2017
Q2
$5.89M Sell
73,953
-9,400
-11% -$749K 0.15% 153
2017
Q1
$5.92M Buy
83,353
+33,087
+66% +$2.35M 0.14% 179
2016
Q4
$2.57M Buy
+50,266
New +$2.57M 0.06% 362